Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON28150Not yet recruiting
Randomised, double-blind trial in cystic fibrosis (CF) comparing Hypertonic saline with Isotonic saline control (2 arms). Primary endpoint: Difference in PRAGMA-CF %Dis at 48 weeks. Planned start May 2016; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON28150.